Trial intelligence / Profile preview

Prasugrel in Aspirin-Exacerbated Respiratory Disease

NCT01597375Phase 2Completed

Start
Aug 2012
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of prasugrel in Aspirin Exacerbated Respiratory Disease (AERD). Started Aug 2012; status: completed.

02

Drugs

prasugrel
03

Conditions

Aspirin Exacerbated Respiratory Disease (AERD)

Beyond the preview

Go deeper on NCT01597375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01597375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call